Role of biomarkers in community-acquired pneumonia management
Autor: | Bahaeddin Onur, Hakan Barış Demirbas, Arif Gulmez |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Journal of Acute Disease, Vol 13, Iss 3, Pp 87-92 (2024) |
Druh dokumentu: | article |
ISSN: | 2221-6189 2589-5516 |
DOI: | 10.4103/jad.jad_65_24 |
Popis: | Community-acquired pneumonia (CAP) poses a significant global health threat, particularly affecting vulnerable populations. Biomarkers and scoring systems play a crucial role in diagnosing, assessing severity, and guiding treatment decisions for CAP patients. Biomarkers like C reactive protein, procalcitonin, and the neutrophil-to-lymphocyte ratio aid in diagnosis and severity assessment, while scoring systems such as CURB-65 and Pneumonia Severity Index classify patients into risk categories. Emerging biomarkers (uremia, elevated respiratory rate, hypotension, and age ≥ 65) like serum amyloid A and S100 proteins show promise in predicting disease severity and prognosis. However, further research is needed to determine their precise roles and clinical utility in CAP management. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |